This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989;44(3):445-54.

doi: 10.1016/0163-7258(89)90010-7.

Nifedipine: variability in its kinetics and metabolism in man

D D Breimer¹, J H Schellens, P A Soons

Affiliations

PMID: 2519350
DOI: 10.1016/0163-7258(89)90010-7

Review

Nifedipine: variability in its kinetics and metabolism in man

D D Breimer et al. Pharmacol Ther. 1989.

. 1989;44(3):445-54.

doi: 10.1016/0163-7258(89)90010-7.

Authors

D D Breimer¹, J H Schellens, P A Soons

Affiliation

¹ Division of Pharmacology, University of Leiden, The Netherlands.

PMID: 2519350
DOI: 10.1016/0163-7258(89)90010-7

No abstract available

PubMed Disclaimer

Similar articles

The first pass metabolism of nifedipine in man.
Waller DG, Renwick AG, Gruchy BS, George CF. Waller DG, et al. Br J Clin Pharmacol. 1984 Dec;18(6):951-4. doi: 10.1111/j.1365-2125.1984.tb02569.x. Br J Clin Pharmacol. 1984. PMID: 6529535 Free PMC article.
Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes.
Choi YH, Lee MG. Choi YH, et al. Xenobiotica. 2012 May;42(5):483-95. doi: 10.3109/00498254.2011.633177. Epub 2012 Mar 14. Xenobiotica. 2012. PMID: 22416982
[Bioavailability and pharmacokinetics of a new nifedipine preparation in healthy volunteers].
Hutt V, Molz KH, Pabst G, Dilger C, Mosberg H, Jaeger H. Hutt V, et al. Arzneimittelforschung. 1989 May;39(5):607-11. Arzneimittelforschung. 1989. PMID: 2757680 Clinical Trial. German.
Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humans.
Schellens JH, Ghabrial H, van der Wart HH, Bakker EN, Wilkinson GR, Breimer DD. Schellens JH, et al. Clin Pharmacol Ther. 1991 Nov;50(5 Pt 1):520-8. doi: 10.1038/clpt.1991.177. Clin Pharmacol Ther. 1991. PMID: 1934865
[Clinical pharmacokinetics of verapamil and nifedipine].
Rumiantsev DO, Piotrovskiĭ VK, Metelitsa VI. Rumiantsev DO, et al. Farmakol Toksikol. 1985 Jan-Feb;48(1):99-109. Farmakol Toksikol. 1985. PMID: 3884367 Review. Russian. No abstract available.

See all similar articles

Cited by

Lack of presystemic metabolism of nifedipine in the rabbit.
du Souich P, Héroux L, Maurice H, Dépôt M, Caillé G. du Souich P, et al. J Pharmacokinet Biopharm. 1995 Dec;23(6):567-80. doi: 10.1007/BF02353462. J Pharmacokinet Biopharm. 1995. PMID: 8733947
Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies.
Donato MT, Castell JV. Donato MT, et al. Clin Pharmacokinet. 2003;42(2):153-78. doi: 10.2165/00003088-200342020-00004. Clin Pharmacokinet. 2003. PMID: 12537515 Review.
Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.
Murdoch D, Brogden RN. Murdoch D, et al. Drugs. 1991 May;41(5):737-79. doi: 10.2165/00003495-199141050-00006. Drugs. 1991. PMID: 1712708 Review.
Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.
Zhou S, Yung Chan S, Cher Goh B, Chan E, Duan W, Huang M, McLeod HL. Zhou S, et al. Clin Pharmacokinet. 2005;44(3):279-304. doi: 10.2165/00003088-200544030-00005. Clin Pharmacokinet. 2005. PMID: 15762770 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science